Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

Diabetes Care
Samy I McFarlaneJ R Sowers

Abstract

There are national mandates to reduce blood pressure (BP) to <130/85 mmHg, LDL cholesterol to <100 mg/dl, and HbA(1c) to <7% and to institute aspirin therapy in patients with diabetes. The objective of this study was to determine the proportion of patients in urban institutions with diabetes and hypertension who meet these treatment goals. Using American Diabetes Association (ADA) guidelines, we evaluated the control of cardiovascular disease (CVD) risk factors in 1,372 patients receiving medical care at two major urban medical centers in Brooklyn and Detroit. Information was extracted from charts of outpatient clinics. Of 1,372 active clinic patients with diabetes and hypertension, 1,247 (90.9%) had type 2 diabetes, and 26.7% met the target blood pressure of 130/85 mmHg. A total of 35.5% met the goal LDL cholesterol level of <100 mg/dl, 26.7% had an HbA(1c) <7%, and 45.6% were on antiplatelet therapy. Only 3.2% of patients met the combined ADA goal for BP, LDL cholesterol, and HbA(1c). Optimal control of CVD risk factors in adults with diabetes was achieved only in a minority of patients. Results reflect the inherent difficulties in achieving these complex guidelines in our present health care systems.

Associated Clinical Trials

References

Dec 5, 1998·The New England Journal of Medicine·UNKNOWN Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group
Dec 31, 1998·The New England Journal of Medicine·D R BerlowitzM A Moskowitz
May 21, 1999·Archives of Internal Medicine·T C Fagan, J Sowers
Sep 8, 2000·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·G L BakrisJ Sowers
Feb 24, 2001·Diabetes Care·A KrautC Mustard
Jun 20, 2001·American Journal of Hypertension·B M EganT L Goodfriend

❮ Previous
Next ❯

Citations

May 24, 2003·Current Diabetes Reports·Mihaela C BlendeaJames R Sowers
May 24, 2003·Current Diabetes Reports·Samy I McFarlaneJ Thomas Bigger
May 11, 2004·Current Diabetes Reports·Fadi A El-AtatJ Thomas Bigger
Jun 3, 2005·Current Diabetes Reports·Fadi El-AtatSamy I McFarlane
Jun 3, 2005·Current Diabetes Reports·John NicasioJudith H LaRosa
Aug 11, 2006·Current Diabetes Reports·Samy I McFarlaneJames R Sowers
Aug 11, 2006·Current Diabetes Reports·Pantelis A SarafidisGeorge L Bakris
Jun 6, 2007·Current Diabetes Reports·Amal FaragSamy I McFarlane
Jun 6, 2009·Current Diabetes Reports·Lisel M Loney-HutchinsonSamy I McFarlane
Nov 19, 2010·Current Diabetes Reports·Jocelyne G Karam, Samy I McFarlane
May 7, 2004·Current Hypertension Reports·Fadi El-AtatJames R Sowers
Jun 9, 2009·The New England Journal of Medicine·UNKNOWN BARI 2D Study GroupBurton E Sobel
May 19, 2007·Antioxidants & Redox Signaling·Syed ShahSamy I McFarlane
Mar 29, 2008·Metabolic Syndrome and Related Disorders·M A Charles, J L Selam
Oct 2, 2003·The Journal of Cardiovascular Nursing·Deborah A ChyunGail D Melkus
Nov 9, 2005·Current Opinion in Lipidology·Eyal LeibovitzDov Gavish
Nov 24, 2004·Southern Medical Journal·William H BestermannBrent M Egan
Dec 21, 2010·Academic Medicine : Journal of the Association of American Medical Colleges·Jason ZuckerSteven Keller
May 14, 2008·Southern Medical Journal·Rakesh ShrivastavaPratap C Reddy
Dec 23, 2004·Kidney International. Supplement·Salvador TrancheUNKNOWN Karen AP Study Investigators
Jan 19, 2005·The Journal of Clinical Hypertension·Marayann N Mugo, James R Sowers
Sep 15, 2006·Journal of General Internal Medicine·George L JacksonMorris Weinberger
May 17, 2007·International Journal of Clinical Practice·D Orozco-BeltránUNKNOWN Collaborative Diabetes Study Investigators
Sep 24, 2010·International Journal of Clinical Practice·A Ceriello
Mar 29, 2012·International Journal of Clinical Practice·M F B BragaUNKNOWN Diabetes Registry to Improve Vascular Events [DRIVE] Investigators
Dec 3, 2005·Cardiovascular Diabetology·Shaun R MillerCharles D MacLean
May 10, 2007·The Review of Diabetic Studies : RDS·Marilia de Brito GomesSérgio Atala Dib
Oct 12, 2011·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Mahmoud Reza SohrabiMazyar Khakpour
Jan 1, 2010·Integrated Blood Pressure Control·Gerti Tashko, Robert A Gabbay
Dec 2, 2005·Treatments in Endocrinology·Craig S StumpJames R Sowers
Oct 14, 2011·Vojnosanitetski pregled. Military-medical and pharmaceutical review·Anujka SeleaDragan Micić
Oct 7, 2011·Journal of Graduate Medical Education·Eileen MastersonCharles K Francis
Mar 21, 2007·The Consultant Pharmacist : the Journal of the American Society of Consultant Pharmacists·Jack M RosenbergHoward McGuire
Feb 8, 2011·Journal of Immigrant and Minority Health·Maria I Van RompayKatherine L Tucker
Feb 23, 2007·Irish Journal of Medical Science·M SherlockC J Thompson
Mar 22, 2014·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Justin PresseauFalko F Sniehotta
Dec 17, 2011·Current Cardiology Reports·Kimia Ghaznavi, Shaista Malik
Mar 7, 2007·Expert Review of Cardiovascular Therapy·Yohannes GebreegziabherSamy I McFarlane
Nov 11, 2009·Expert Review of Cardiovascular Therapy·Samy I McFarlane
May 14, 2011·Expert Opinion on Biological Therapy·Ram KelaMelanie J Davies

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.

CV Disorders & Type 2 Diabetes

This feed focuses on the association of cardiovascular diseases in patients with type 2 diabetes.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Cardiovascular Disorder in Diabetes

Diabetes is associated with an increased risk of cardiovascular disorders and heart failure. Discover the latest research here.

American Diabetes Association Journals

Discover the latest diabetes research published by the journals from the American Diabetes Association.

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.